Long-Term Efficacy and Safety of Ipragliflozin plus Insulin in Japanese Patients with Type 2 Diabetes (IOLITE)

被引：0
|
作者：
Ishihara, Hisamitsu
Yamaguchi, Susumu
Nakao, Ikko
Okitsu, Akira
Asahina, Seitaro
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1250-P
引用
收藏
页码：A335 / A335
页数：1
相关论文
共 50 条
  • [21] Long-term safety, tolerability, and efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes
    Odawara M.
    Kadowaki T.
    Tajima N.
    Nishii M.
    Taniguchi T.
    Ferreira J.C.A.
    Diabetology International, 2011, 2 (2) : 94 - 105
  • [22] Long-term (52-week) efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open-label extension of a phase III study
    Kaku, Kohei
    Isaka, Hiroyuki
    Sakatani, Taishi
    Toyoshima, Junko
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (03) : 662 - 671
  • [23] Long-term Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes, Cardiovascular Disease, and Hypertension
    Cefalu, William T.
    Gause-Nilsson, Ingrid Ami
    De Bruin, Tjerk W. A.
    Sugg, Jennifer E.
    Parikh, Shamik J.
    Johnsson, Eva
    DIABETES, 2014, 63 : A286 - A286
  • [24] Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment
    Newman, J.
    McGill, J. B.
    Patel, S.
    Friedrich, C.
    Sauce, C.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S333 - S333
  • [25] Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin
    Kato M.
    Sakai K.
    Saito K.
    Tsutsui K.
    Yamashita S.
    Kato N.
    Diabetology International, 2017, 8 (3) : 275 - 285
  • [26] Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial
    Araki, Eiichi
    Unno, Yuriko
    Tanaka, Yuko
    Sakamoto, Wataru
    Miyamoto, Yuki
    ADVANCES IN THERAPY, 2019, 36 (10) : 2697 - 2711
  • [27] Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial
    Eiichi Araki
    Yuriko Unno
    Yuko Tanaka
    Wataru Sakamoto
    Yuki Miyamoto
    Advances in Therapy, 2019, 36 : 2697 - 2711
  • [28] Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia Long-term safety and efficacy of fostamatinib
    Kuwana, Masataka
    Tomiyama, Yoshiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (03) : 356 - 362
  • [29] Efficacy and Safety of Ipragliflozin in Patients With Type 2 Diabetes: ASSIGN-K Study
    Iemitsu, Kotaro
    Kawata, Takehiro
    Iizuka, Takashi
    Takihata, Masahiro
    Takai, Masahiko
    Nakajima, Shigeru
    Minami, Nobuaki
    Umezawa, Shinichi
    Kanamori, Akira
    Takeda, Hiroshi
    Ito, Shogo
    Kikuchi, Taisuke
    Amemiya, Hikaru
    Kaneshiro, Mizuki
    Mokubo, Atsuko
    Takuma, Tetsuo
    Machimura, Hideo
    Tanaka, Keiji
    Asakura, Taro
    Kubota, Akira
    Aoyagi, Sachio
    Hoshino, Kazuhiko
    Ishikawa, Masashi
    Matsuzawa, Yoko
    Obana, Mitsuo
    Sasai, Nobuo
    Kaneshige, Hideaki
    Minagawa, Fuyuki
    Saito, Tatsuya
    Shinoda, Kazuaki
    Miyakawa, Masaaki
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2019, 9 (03) : 51 - 62
  • [30] Long-term efficacy and safety of add-on therapy of vildagliptin in type 2 diabetes mellitus with insulin treatment
    Kanazawa, Ippei
    Tanaka, Ken-ichiro
    Notsu, Masakazu
    Tanaka, Sayuri
    Kiyohara, Nobuaki
    Koike, Sayo
    Yamane, Yuko
    Tada, Yuko
    Sasaki, Motofumi
    Yamauchi, Mika
    Sugimoto, Toshitsugu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S107 - S107
12345